The antifungal voriconazole is effective for the treatment of invasive fungal infections in immunocompromised patients. A serious adverse reaction is QT interval prolongation, which may precede life-threatening arrhythmias, such as torsades de pointes. Although ventricular arrhythmias are mentioned as a possible adverse effect of voriconazole, thus far, the incidence and clear recommendations for QT follow-up have not been published. This prospective observational study aimed at describing the incidence of voriconazole induced- QT interval prolongation in the pediatric population and determine the risk factors for this phenomenon.
Study Type
OBSERVATIONAL
Enrollment
60
Schneider childrens medical center of Isreal
Petah Tikva, Israel
QT interval prolongation
Time frame: up to three months of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.